The DOI matches its Crossref record; 145 of the 150 references it cites were found in a registry or an index.
Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies
Abstract
Intracranial self-administration (ICSA) and intracranial place conditioning (ICPC) methodologies have been mainly used to study drug reward mechanisms, but they have also been applied toward examining brain reward mechanisms. ICSA studies in rodents have established that the ventral tegmental area (VTA) is a site supporting morphine and ethanol reinforcement. ICPC studies confirmed that injection of morphine into the VTA produces conditioned place preference (CPP). Further confirmation that activation of opioid receptors within the VTA is reinforcing comes from the findings that the endogenous opioid peptide met-enkephalin injected into the VTA produces CPP, and that the mu- and delta-opioid agonists, DAMGO and DPDPE, are self-infused into the VTA. Activation of the VTA dopamine (DA) system may produce reinforcing effects in general because (a) neurotensin is self-administered into the VTA, and injection of neurotensin into the VTA produces CPP and enhances DA release in the nucleus accumbens (NAC), and (b) GABA(A) antagonists are self-administered into the anterior VTA and injections of GABA(A) antagonists into the anterior VTA enhance DA release in the NAC. The NAC also appears to have a major role in brain reward mechanisms, whereas most data from ICSA and ICPC studies do not support an involvement of the caudate-putamen in reinforcement processes. Rodents will self-infuse a variety of drugs of abuse (e.g. amphetamine, morphine, phencyclidine and cocaine) into the NAC, and this occurs primarily in the shell region. ICPC studies also indicate that injection of amphetamine into the shell portion of the NAC produces CPP. Activation of the DA system within the shell subregion of the NAC appears to play a key role in brain reward mechanisms. Rats will ICSA the DA uptake blocker, nomifensine, into the NAC shell; co-infusion with a D2 antagonist can block this behavior. In addition, rats will self-administer a mixture of a D1 plus a D2 agonist into the shell, but not the core, region of the NAC. The ICSA of this mixture can be blocked with the co-infusion of either a D1 or a D2 antagonist. However, the interactions of other transmitter systems within the NAC may also play key roles because NMDA antagonists and the muscarinic agonist carbachol are self-infused into the NAC. The medial prefrontal (MPF) cortex supports the ICSA of cocaine and phencyclidine. The DA system also seems to play a role in this behavior since cocaine self-infusion into the MPF cortex can be blocked by co-infusing a D2 antagonist, or with 6-OHDA lesions of the MPF cortex. Limited studies have been conducted on other CNS regions to elucidate their role in brain and drug reward mechanisms using ICSA or ICPC procedures. Among these regions, ICPC findings suggest that cocaine and amphetamine are rewarding in the rostral ventral pallidum (VP); ICSA and ICPC studies indicate that morphine is rewarding in the dorsal hippocampus, central gray and lateral hypothalamus. Finally, substance P mediated systems within the caudal VP (nucleus basalis magnocellularis) and serotonin systems of the dorsal and median raphe nuclei may also be important anatomical components involved in brain reward mechanisms. Overall, the ICSA and ICPC studies indicate that there are a number of receptors, neuronal pathways, and discrete CNS sites involved in brain reward mechanisms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reward information is processed via a limbic cortico-striatal-thalamic circuit that interdigitates with the mesolimbic DA pathway [56,57], and the NAc serves as a DA-gated mediator for information passing from the limbic system to the cortex [58].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [57]
In the citing paper
“Moreover, drugs that enhance operant responding for such food rewards, such as amphetamine, are most effective when administered into the NAc, whereas DA receptor antagonists administered into the NAc block the stimulant effects [57,311].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [57]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Skinner, B. F. (1938) · Cited by 3,571
Olds, J., & Milner, P. (1954) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0058775 · Cited by 3,176
Conditioned Reflexes: An Investigation of the Physiological Activity of the Cerebral Cortex.
Pavlov, P. I. (1930) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1930.02220110256018 · Cited by 2,681
Taussig, M. (1991) · Routledge eBooks · doi:10.4324/9780203397244 · Cited by 2,403
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Wise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
Conditioned Reflexes: an Investigation of the Physiological Activity of the Cerebral Cortex
Denny-Brown, D. E. (1928) · Nature · doi:10.1038/121662a0 · Cited by 1,854
The organization of the projection from the cerebral cortex to the striatum in the rat
McGeorge, A. J., & Faull, R. L. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90128-0 · Cited by 1,360
Research works printed but not linked: 3
- Iwamoto, 1986, Place-aversion conditioned by phencyclidine in rats: development of tolerance and pharmacological antagonism, Alcohol. Drug Res., 6, 265
- McKinzie, 1997, Cocaine is self-administered into the anterior nucleus accumbens shell region of alcohol-preferring P rats, Soc. Neurosci. Abs., 23, 1105
- Rodd, 1998, Intracranial self-administration of ethanol into the posterior VTA by Wistar rats, Soc. Neurosci. Abs., 24, 1479
Cited by
Sorted by citations
Items 201–300 of 574
Rezayof, A., Razavi, S., Haeri-Rohani, A., Rassouli, Y., & Zarrindast, M. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.02.003 · Cited by 50
Shin, R. S., Qin, M., Liu, Z., & Ikemoto, S. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1131-x · Cited by 47
Self-citationLénárd, L., László, K., Kertes, E., Ollmann, T., Péczely, L., Kovács, A., Kállai, V., Zagorácz, O., Gálosi, R., & Karádi, Z. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.09.003 · Cited by 49
Singh, A. K. (2019) · Biomedicines · doi:10.3390/biomedicines7010016 · Cited by 51
Kingsbury, M. A., & Wilson, L. C. (2016) · Integrative and Comparative Biology · doi:10.1093/icb/icw122 · Cited by 48
Misra, K., & Pandey, S. C. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10831 · Cited by 48
Zarrindast, M., Karami, M., Sepehri, H., & Sahraei, H. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02328-2 · Cited by 48
Vazquez-DeRose, J., Stauber, G. B., Khroyan, T. V., Xie, X., Zaveri, N. T., & Toll, L. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.050 · Cited by 48
Onaolapo, O. J., Aremu, O. S., & Onaolapo, A. Y. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-017-1371-6 · Cited by 47
Rodd, Z. A., Bell, R. L., McQueen, V. K., Davids, M. R., Hsu, C. C., Murphy, J. M., Li, T., Lumeng, L., & McBride, W. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084350 · Cited by 47
Self-citationZarrindast, M., Fatahi, Z., Rostami, P., & Rezayof, A. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.02.018 · Cited by 47
McBride, W. J., Kimpel, M. W., McClintick, J. N., Ding, Z., Hyytiä, P., Colombo, G., Edenberg, H. J., Lumeng, L., & Bell, R. L. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.04.016 · Cited by 46
Self-citationWille‐Bille, A., Miranda‐Morales, R. S., Pucci, M., Bellia, F., D’Addario, C., & Pautassi, R. M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.04.005 · Cited by 48
Neuropeptide Regulation of Social Attachment: The Prairie Vole Model
Tabbaa, M., Paedae, B., Liu, Y., & Wang, Z. (2016) · Comprehensive physiology · doi:10.1002/cphy.c150055 · Cited by 54
Sotomayor, R., Forray, M. I., & Gysling, K. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20537 · Cited by 45
BIG News in Alcohol Addiction: New Findings on Growth Factor Pathways BDNF, Insulin, and GDNF
Janak, P. H., Wolf, F. W., Heberlein, U., Pandey, S. C., Logrip, M. L., & Dorit Ron, A. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00026.x · Cited by 45
Liang, J., Ping, X., Li, Y.-J., Ma, Y., Wu, L., Han, J., & Cui, C. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.007 · Cited by 44
Gieryk, A., Ziółkowska, B., Solecki, W., Kubik, J., & Przewłocki, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1730-1 · Cited by 44
Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area
Moreno, E., Quiroz, C., Rea, W. P., Cai, N.-S., Mallol, J., Cortés, A., Lluı́s, C., Canela, E. I., Casadó, V., & Ferré, S. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2442-16.2016 · Cited by 44
Mielenz, D., Reichel, M., Jia, T., Quinlan, E. B., Stöckl, T., Mettang, M., Zilske, D., Kirmizi-Alsan, E., Schönberger, P., Praetner, M., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.63 · Cited by 44
Friend, L. N., Weed, J., Sandoval, P. J., Nufer, T. M., Ostlund, I., & Edwards, J. G. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0190-17.2017 · Cited by 47
Ventral pallidal encoding of reward-seeking behavior depends on the underlying associative structure
Richard, J. M., Stout, N., Acs, D., & Janak, P. H. (2018) · eLife · doi:10.7554/elife.33107 · Cited by 46
Sahraei, H., Fatemi, S. M., Pashaei-Rad, S., Faghih-Monzavi, Z., Salimi, S. H., & Kamalinegad, M. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.08.022 · Cited by 44
Ding, Z., Oster, S. M., Hall, S. R., Engleman, E. A., Hauser, S. R., McBride, W. J., & Rodd, Z. A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2208-5 · Cited by 44
Self-citationSerotonin's Complex Role in Alcoholism: Implications for Treatment and Future Research
Marcinkiewcz, C. A., Lowery‐Gionta, E. G., & Kash, T. L. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13076 · Cited by 43
Misra, K., & Pandey, S. C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300900 · Cited by 44
McBride, W. J., Kimpel, M. W., McClintick, J. N., Ding, Z., Hauser, S. R., Edenberg, H. J., Bell, R. L., & Rodd, Z. A. (2013) · Alcohol · doi:10.1016/j.alcohol.2013.04.002 · Cited by 43
Self-citationDeehan, G. A., McKinzie, D. L., Carroll, F. I., McBride, W. J., & Rodd, Z. A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.006 · Cited by 44
Self-citationJang, E. Y., Choe, E. S., Hwang, M., Kim, S. C., Lee, J. R., Kim, S. G., Jeon, J., Buono, R. J., & Yang, C. H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.054 · Cited by 43
Rodd, Z. A., Gryszowka, V. E., Toalston, J. E., Oster, S. M., Ji, D., Bell, R. L., & McBride, W. J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.112607 · Cited by 43
Self-citationRepeated stress in young and old 5-HT2C receptor knockout mice
Chou-Green, J. M., Holscher, T. D., Dallman, M. F., & Akana, S. F. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00096-9 · Cited by 43
Sahraei, H., Ghazzaghi, H., Zarrindast, M., Ghoshooni, H., Sepehri, H., & Haeri-Rohan, A. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.03.004 · Cited by 42
Synaptic plasticity mechanisms common to learning and alcohol use disorderPreprint
Lovinger, D. M., & Abrahao, K. P. (2018) · Learning & Memory · doi:10.1101/lm.046722.117 · Cited by 47
Modulation of cellular activity and synaptic transmission in the ventral tegmental area
Mathon, D. S., Kamal, A., Smidt, M. P., & Ramakers, G. M. J. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.097 · Cited by 41
Müller, C. P. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112672 · Cited by 45
Rodd, Z. A., Bell, R. L., McQueen, V. K., Davids, M. R., Hsu, C. C., Murphy, J. M., Li, T., Lumeng, L., & McBride, W. J. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000156127.30983.9d · Cited by 41
Self-citationRezayof, A., Amini, R., Rassouli, Y., & Zarrindast, M. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.03.017 · Cited by 41
Hayes, D. J., Mosher, T. M., & Greenshaw, A. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.08.034 · Cited by 41
Carr, K. D., de Vaca, S. C., Sun, Y., & Chau, L. S. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1355-9 · Cited by 41
Asyyed, A. H., Storm, D. R., & Diamond, I. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.107 · Cited by 41
Darbandi, N., Rezayof, A., & Zarrindast, M. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.04.001 · Cited by 40
What is in that Drink: The Biological Actions of Ethanol, Acetaldehyde, and Salsolinol
Deehan, G. A., Brodie, M. S., & Rodd, Z. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_198 · Cited by 39
Neurotensin: A role in substance use disorder?
Ferraro, L., Fasiolo, L. T., Beggiato, S., Borelli, A. C., Pomierny-Chamioło, L., Frankowska, M., Antonelli, T., Tomasini, M. C., Fuxé, K., & Filip, M. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881115622240 · Cited by 39
Pluzarev, O., & Pandey, S. C. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20216 · Cited by 39
Carnicella, S., Ahmadiantehrani, S., He, D., Nielsen, C. K., Bartlett, S. E., Janak, P. H., & Dorit Ron, A. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.022 · Cited by 39
Galanin – 25 years with a multitalented neuropeptide
Picciotto, M. R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8151-x · Cited by 39
Starkey, J. A., Mechref, Y. S., Muzikář, J., McBride, W. J., & Novotný, M. V. (2006) · Analytical Chemistry · doi:10.1021/ac051863j · Cited by 39
Self-citationMisra, K., & Pandey, S. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.41 · Cited by 39
Ibrahim, K. M., Massaly, N., Yoon, H. J., Sandoval, R., Widman, A. J., Heuermann, R. J., Williams, S. B., Post, W., Pathiranage, S., Lintz, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44836-9 · Cited by 41
Pharmacologic Dissociation Between Impulsivity and Alcohol Drinking in High Alcohol Preferring Mice
Oberlin, B. G., Bristow, R. E., Heighton, M. E., & Grahame, N. J. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01220.x · Cited by 39
Ballesteros‐Yáñez, I., Ambrosio, E., Benavides‐Piccione, R., Perez, J., Torres, I., Miguéns, M., Garcı́a-Lecumberri, C., & DeFelipe, J. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj142 · Cited by 37
Bunney, E. B., Appel, S. B., & Brodie, M. S. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39246-8 · Cited by 38
Rezayof, A., Sardari, M., Zarrindast, M., & Nayer-Nouri, T. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.023 · Cited by 37
Carey, R. J., Huston, J. P., & Müller, C. P. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00917-5 · Cited by 36
Merrer, J. L., Gavello-Baudy, S., Galey, D., & Cazala, P. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.03.014 · Cited by 37
Inhibition of cocaine self-administration by fluoxetine or d-fenfluramine combined with phentermine
Glatz, A. C., Ehrlich, M. E., Bae, R. S., Clarke, M. J., Quinlan, P. A., Brown, E. C., Rada, P. V., & Hoebel, B. G. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00657-8 · Cited by 36
Learning the morphine conditioned cue preference: Cue configuration determines effects of lesions
White, N. M., Chai, S.-C., & Hamdani, S. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.06.002 · Cited by 36
Jing, M., Han, X., Zhao, T.-Y., Wang, Z., Lu, G.-Y., Wu, N., Song, R., & Li, J. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00442-z · Cited by 33
Saulskaya, N. B., & Mikhailova, M. O. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00126-4 · Cited by 35
Anxiogenic-Like Effects Limit Rewarding Effects of Cocaine in BALB/cByJ Mice
David, V. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00205-0 · Cited by 35
αCaMKII controls the establishment of cocaine's reinforcing effects in mice and humans
Easton, A. C., Lourdusamy, A., Havranek, M. M., Mizuno, K., Solati, J., Golub, Y., Clarke, T., Vallada, H., Laranjeira, R., Desrivières, S., et al. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.97 · Cited by 34
FOS expression induced by an ethanol-paired conditioned stimulus
Hill, K., Ryabinin, A. E., & Cunningham, C. L. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.04.017 · Cited by 35
Rewal, M., Donahue, R., Gill, T. M., Nie, H., Ron, D., & Janak, P. H. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00333.x · Cited by 34
Müller, C. P., & Huston, J. P. (2007) · Synapse · doi:10.1002/syn.20366 · Cited by 34
David, V., & Cazala, P. (2000) · Psychopharmacology · doi:10.1007/s002130000425 · Cited by 33
Misra, K., Roy, A., & Pandey, S. C. (2001) · Neuroreport · doi:10.1097/00001756-200112210-00054 · Cited by 34
Rada, P. V., & Hoebel, B. G. (2001) · Brain Research · doi:10.1016/s0006-8993(00)02865-1 · Cited by 34
Mejías-Aponte, C. A., Ye, C.-Q., Bonci, A., Kiyatkin, E. A., & Morales, M. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3422-13.2015 · Cited by 37
Merrer, J. L., Faget, L. C., Matifas, A., & Kieffer, B. L. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2693-1 · Cited by 33
Vena, A. A., Zandy, S. L., Cofresí, R. U., & Gonzales, R. A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107573 · Cited by 33
Newman, S. M., Pascal, L., Sadeghian, K., & Baldo, B. A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.027 · Cited by 33
Alcohol-preferring AA rats show a derangement in their central melanocortin signalling system
Lindblom, J., Wikberg, J. E. S., & Bergström, L. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00719-0 · Cited by 33
Müller, C. P., Schumann, G., Rehm, J. T., Kornhuber, J., & Lenz, B. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02074-3 · Cited by 34
McCue, D. L., Kasper, J. M., & Hommel, J. D. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.178 · Cited by 32
Social and sexual motivation in the mouse.
Matthews, T. J., Abdelbaky, P., & Pfaff, D. W. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.6.1628 · Cited by 32
Ettenberg, A., & Bernardi, R. E. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.04.014 · Cited by 33
Wang, W., Zhou, Y., Sun, J., Pan, L., Kang, L., Dai, Z., Yu, R., Jin, G.-Z., & Ma, L. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.08.006 · Cited by 32
Bahí, A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.122 · Cited by 31
Combined approaches for the relief of spinal cord injury-induced neuropathic pain
Gwak, Y. S., Kim, H. Y., Lee, B. H., & Yang, C. H. (2016) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2015.12.021 · Cited by 31
Progesterone enhances learning and memory of aged wildtype and progestin receptor knockout mice
Frye, C. A., & Walf, A. A. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.01.051 · Cited by 31
Peoples, L. L., Kravitz, A. V., Lynch, K. G., & Cavanaugh, D. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301203 · Cited by 31
Central reinforcing effects of ethanol are blocked by catalase inhibition
Nizhnikov, M. E., Molina, J. C., & Spear, N. E. (2007) · Alcohol · doi:10.1016/j.alcohol.2007.08.006 · Cited by 31
Sahraei, H., Etemadi, L., Rostami, P., Pourmotabbed, A., Zarrindast, M., Shams, J., Ghoshooni, H., Noroozzadeh, A., Esfandiari, B., & Salimi, S. H. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.08.015 · Cited by 31
Carboni, E., & Vacca, C. (2003) · Humana Press eBooks · doi:10.1385/1-59259-358-5:481 · Cited by 31
Piri, M., & Zarrindast, M. R. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.11.059 · Cited by 30
Huber, S. E., Zoicas, I., Reichel, M., Mühle, C., Büttner, C., Ekici, A. B., Eulenburg, V., Lenz, B., Kornhuber, J., & Müller, C. P. (2017) · Addiction Biology · doi:10.1111/adb.12540 · Cited by 30
Why Do Birds Flock? A Role for Opioids in the Reinforcement of Gregarious Social Interactions
Riters, L. V., Kelm‐Nelson, C. A., & Spool, J. A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00421 · Cited by 29
A common limiter circuit for opioid choice and relapse identified in a rodent addiction model
Heinsbroek, J. A., Giannotti, G., Mandel, M. R., Josey, M., Aston‐Jones, G., James, M. H., & Peters, J. (2021) · Nature Communications · doi:10.1038/s41467-021-25080-x · Cited by 32
Liao, R. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.009 · Cited by 32
Perseverance of exploration in novel environments predicts morphine place conditioning in rats
Nadal, R. A., Rotllant, D., Márquez, C., & Armario, A. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.06.039 · Cited by 30
Brain activation patterns during classical conditioning with appetitive or aversive UCS
Cybulska-Kłosowicz, A., Zakrzewska, R., & Kossut, M. M. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.05.024 · Cited by 29
Šustková-Fišerová, M., Charalambous, C., Havlickova, T., Lapka, M., Jerabek, P., Puskina, N., & Syslová, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112486 · Cited by 29
Sahraei, H., Amiri, Y.-A., Haeri-Rohani, A., Sepehri, H., Salimi, S. H., Pourmotabbed, A., Ghoshooni, H., Zahirodin, A., & Zardooz, H. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.012 · Cited by 29
Filip, M., & Siwanowicz, J. (2001) · PubMed · Cited by 29
Functional aspects of the ventral pallidum
Kretschmer, B. D. (2000) · Amino Acids · doi:10.1007/s007260070050 · Cited by 29
Vallöf, D., Kalafateli, A. L., & Jerlhag, E. (2019) · Addiction Biology · doi:10.1111/adb.12764 · Cited by 28
Katner, S. N., Oster, S. M., Ding, Z., Deehan, G. A., Toalston, J. E., Hauser, S. R., McBride, W. J., & Rodd, Z. A. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.06.021 · Cited by 28
Self-citationCook, J. B., Werner, D. F., Maldonado‐Devincci, A. M., Leonard, M. N., Fisher, K. R., O’Buckley, T. K., Porcu, P., McCown, T. J., Besheer, J., Hodge, C. W., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4733-13.2014 · Cited by 29
Filip, M., Papla, I., Nowak, E., Czepiel, K., & Przegaliński, E. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02873-x · Cited by 28
Martín‐García, E., Darbra, S., & Pallarés, M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.01.022 · Cited by 27
Metadata
- Authors
- McBride, W. J., Murphy, J. M., & Ikemoto, S.
- Affiliations
- Indiana University Indianapolis (US)
- Corresponding author
- McBride, William J
- Venue
- Behavioural Brain Research
- Publisher
- Elsevier BV
- Published
- 1999-06
- Volume
- 101
- Issue
- 2
- Pages
- 129-152
- ISSN
- 0166-4328 (ISSN-L)
- OpenAlex
- W2129176481
- Cited by
- 574
- References
- 150
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 3 · 2022: 6 · 2021: 10 · 2020: 16 · 2019: 12 · 2018: 20 · 2017: 18 · 2016: 21 · 2015: 17 · 2014: 16 · 2013: 29 · 2012: 23
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Behavioural Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01aa009619-03)
- National Institute on Alcohol Abuse and Alcoholism (AA-07611, AA-07462, T32AA007462, AA09619)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- ventral tegmental area, nucleus accumbens shell, dopamine, opioid receptors, met-enkephalin, conditioned place preference, drug reward, morphine, amphetamine, cocaine, dopamine D1 and D2 receptors, NMDA receptor antagonists, muscarinic receptors
- MeSH terms
- Animals, Brain, Conditioning, Operant, Humans, Receptors, Drug, Receptors, Cell Surface, Reinforcement, Psychology, Reward, Self Administration, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
